DRAWING: Understanding the Strengths and Vulnerabilities of Those Most Impacted by HIV: Implications for Vaccines and Vaccination Campaigns | Courtney Bonner

AIDSImpact 2021 | Webinar Series

DRAWING: Ethics and Equity of Vaccine and Treatment - Comparing and Contrasting HIV & COVID-19 | Adeeba Kamarulzaman

AIDSImpact 2021 | Webinar Series

DRAWING: Vaccine Hesitancy in the Era of Emerging Diseases | Jeremy K. Ward

AIDSImpact 2021 | Webinar Series

DRAWING: Lessons From Vaccines - Two Viruses - Many Questions | Glenda E. Gray

AIDSImpact 2021 | Webinar Series

DRAWING: Children, Adolescents and Two Deadly Viruses | Lucie Cluver, MD

AIDSImpact 2021 | Webinar Series

DRAWING: Moving to mHealth – HIV and Future Care | Jenny Whetham, MD

AIDSImpact 2021 | Webinar Series

DRAWING: What Is Known About COVID-19 Incidence & Outcomes Among Those Living With HIV | Caroline Sabin, PhD

AIDSImpact 2021 | Webinar Series

DRAWING: Will COVID-19 Change Global Policy Regarding HIV? | Michel Kazatchkine, MD

AIDSImpact 2021 | Webinar Series

Burdensome Health-Related Issues Affecting People Living With HIV in Spain in the Context of High Antiretroviral Coverage: A Qualitative Study

Workshop on Healthy Living with HIV 2020

HIV Care for Women Living With HIV in Brighton: A Description of a One-Stop, Integrated Model of Care: The Sunflower Clinic

Workshop on Healthy Living with HIV 2020

Impact of HIV on Treatment and Outcome after Acute Myocardial Infarction: A Swedish Nationwide Observational Cohort Study

Workshop on Healthy Living with HIV 2020

Women Above 50 Navigating Life With New HIV Diagnosis in Rural South Africa: A Phenomenological Study.

Workshop on Healthy Living with HIV 2020

Perceived Barriers on Accessing Reproductive Health Services Among Adolescent and Youth Living With Physiswecal Disability in Ehlanzeni District, Mpumalanga Province, South Africa.

Workshop on Healthy Living with HIV 2020

Pooled Analysis of 4 International Trials of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Adults Aged >65 or Older Demonstrating Safety and Efficacy: Week 48 Results - I. McNicholl

International Workshop on HIV & Aging 2020

Geriatric Syndromes in an Urban Elderly Population in Cameroon: a Focus on Disability, Sarcopenia and Cognitive Impairment - M. Ntsama Essomba

International Workshop on HIV & Aging 2020

Molecular Signatures of Aging and Flu Vaccine Response in Healthy and HIV Infected Individuals - S. Rinaldi

International Workshop on HIV & Aging 2020

Immunological Age Prediction in HIV-Infected, ART-Treated Individuals - L. De Armas

International Workshop on HIV & Aging 2020

Functional Variation in the Haptoglobin Gene Affects Risk of Neurocognitive Impairment in People With HIV During Aging - H. Bai

International Workshop on HIV & Aging 2020

Association of Polyfunctional CMV-Specific T Cells With Frailty in HIV-Infected and -Uninfected Men - W. Zhang

International Workshop on HIV & Aging 2020

A Study of Neurocognitive Performance in Women Living With and Without HIV in South Africa - H. Cassim

International Workshop on HIV & Aging 2020

History of Early Life Stress Strengthens the Link Between VACS Scores and Inflammation Among Older Adults With HIV - H. Derry

International Workshop on HIV & Aging 2020

The Impact of COVID-19 on Health Seeking Behaviors Among Older Adults Living With HIV in the Coachella Valley, California - J. Taylor

International Workshop on HIV & Aging 2020

Associations Between Frailty and Clinical Characteristics, Comorbidities, and Substance Use Among People Living With HIV - S. Ruderman

International Workshop on HIV & Aging 2020

Endocrine NAFLD in People Living With HIV - G. Guaraldi

International Workshop on HIV & Aging 2020